{"id":123279,"name":"NATIONAL SCLERODERMA FOUNDATION","slug":"national-scleroderma-foundation","state":"TX","country":"United States of America","description":"Promotes Compounding Pharmacy Profession","totalSpending":360000,"filings":36,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":50000},{"year":2021,"income":40000},{"year":2022,"income":40000},{"year":2023,"income":60000},{"year":2024,"income":50000},{"year":2025,"income":40000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"}],"firms":["HEALTH AND MEDICINE COUNSEL, LLC"],"lobbyists":["DALE DIRKS","DANE CHRISTIANSEN","PHILIP GOGLAS","KATHERINE CRUZ","JOSHUA FEIN"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE"],"sampleDescriptions":["FY17 & FY18 L-HHS Appropriations Bills (Medical Research & Public Health Programs) \n\nFY17 & FY18 DoD Appropriations Bills (Research Programs)","Scleroderma & Fibrosis Research\n\n21st Century Cures Implementation \n\nPatients Access to Treatments Act \n\nAccess to Marketplace Insurance Act\n\nHealthcare Reform, Patient Protections","Scleroderma & Fibrosis Research\n\n21st Century Cures Implementation \n\nPatients Access to Treatments Act \n\nAccess to Marketplace Insurance Act\n\nHealthcare Reform, Patient Protections","FY17 & FY18 L-HHS Appropriations Bills (Medical Research & Public Health Programs) \n\nFY17 & FY18 DoD Appropriations Bills (Research Programs)","Scleroderma & Fibrosis Research\n\n21st Century Cures Implementation \n\nPatients Access to Treatments Act \n\nAccess to Marketplace Insurance Act\n\nHealthcare Reform, Patient Protections"]}